Statement of Deviation or Variation in the use of proceeds of funds raised through Compulsory Convertible Warrants and Foreign Currency Convertible Bonds (FCCBs).
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eraaya Lifespaces filed its quarterly disclosure confirming that no fresh funds were raised during Q2 FY26 and there is no deviation or variation in how previously raised funds are being used. The filing covers four prior fund raises: two preferential allotments (₹546.75M raised on Jan 18, 2025 and ₹85.05M on Feb 4, 2025) directed at working capital, general corporate purposes, investments in subsidiaries/JVs, and issue expenses, plus two FCCB tranches (₹49.92M on Aug 23, 2024 and ₹49.97M on Oct 3, 2024) earmarked for acquiring 100% of Ebix Inc. Of the FCCB proceeds, ₹16.79M remains unutilized against the Oct 2024 tranche. Importantly, the company disclosed that USD 40 million from the FCCB offering is yet to be received and is subject to legal recovery proceedings in the UK High Court, while an NCLT interim order dated Feb 13, 2025 has directed status quo on all transactions arising from the FCCB offering circular, forcing the company to defer related accounting under Ind AS 32. Care Rating Limited acted as monitoring agency for the preferential allotments.
Neutral-to-negative for shareholders: while no deviation from stated objects is reported, the FCCB-related disclosures highlight ongoing legal uncertainty (UK recovery suit, NCLT status quo order, deferred accounting) around the Ebix Inc acquisition funding, and large unutilized balances (e.g., only ~₹547M deployed out of ~₹2,187M modified allocation in one tranche) signal slow execution of stated plans.